title: [Adverse reactions and intracranial contrast medium after myelography].
abstract: Correlation between adverse reactions and intracranial contrast media after myelography was studied. Myelography was carried out for 12 cases with metrizamide and 14 with iotrolan. In all patients, cranial CT scans were performed 18 approximately 22 hours after myelography. CT attenuation value of subarachnoid cistern was higher than the gray matter in 12 cases and lower in 14 cases. Six cases suffered from adverse reactions, but only 1 case belongs to the higher group. No correlation between adverse reactions and residual amount of contrast medium on CT was recognized.
authors.forename: K
authors.initials: K
authors.lastname: Fujii
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
authors.forename: M
authors.initials: M
authors.lastname: Isaza
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
authors.forename: N
authors.initials: N
authors.lastname: Hirabuki
authors.forename: T
authors.initials: T
authors.lastname: Miura
authors.forename: M
authors.initials: M
authors.lastname: Mitomo
authors.forename: T
authors.initials: T
authors.lastname: Kozuka
authors.forename: R
authors.initials: R
authors.lastname: Kawai
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D003287:Contrast Media / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects*; D008297:Male; D008793:Metrizamide / Q000009:adverse effects* / Q000493:pharmacokinetics; D008875:Middle Aged; D009192:Myelography; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; C033300:iotrolan; D008793:Metrizamide